Correlation Between Ensysce Biosciences and Oncotelic Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ensysce Biosciences and Oncotelic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ensysce Biosciences and Oncotelic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ensysce Biosciences and Oncotelic Therapeutics, you can compare the effects of market volatilities on Ensysce Biosciences and Oncotelic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ensysce Biosciences with a short position of Oncotelic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ensysce Biosciences and Oncotelic Therapeutics.
Diversification Opportunities for Ensysce Biosciences and Oncotelic Therapeutics
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Ensysce and Oncotelic is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Ensysce Biosciences and Oncotelic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncotelic Therapeutics and Ensysce Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ensysce Biosciences are associated (or correlated) with Oncotelic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncotelic Therapeutics has no effect on the direction of Ensysce Biosciences i.e., Ensysce Biosciences and Oncotelic Therapeutics go up and down completely randomly.
Pair Corralation between Ensysce Biosciences and Oncotelic Therapeutics
Given the investment horizon of 90 days Ensysce Biosciences is expected to generate 4.64 times less return on investment than Oncotelic Therapeutics. But when comparing it to its historical volatility, Ensysce Biosciences is 1.44 times less risky than Oncotelic Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Oncotelic Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 3.00 in Oncotelic Therapeutics on August 31, 2024 and sell it today you would lose (0.80) from holding Oncotelic Therapeutics or give up 26.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 8.56% |
| Values | Daily Returns |
Ensysce Biosciences vs. Oncotelic Therapeutics
Performance |
| Timeline |
| Ensysce Biosciences |
| Oncotelic Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Ensysce Biosciences and Oncotelic Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ensysce Biosciences and Oncotelic Therapeutics
The main advantage of trading using opposite Ensysce Biosciences and Oncotelic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ensysce Biosciences position performs unexpectedly, Oncotelic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncotelic Therapeutics will offset losses from the drop in Oncotelic Therapeutics' long position.| Ensysce Biosciences vs. Zura Bio Limited | Ensysce Biosciences vs. Phio Pharmaceuticals Corp | Ensysce Biosciences vs. Sonnet Biotherapeutics Holdings | Ensysce Biosciences vs. 180 Life Sciences |
| Oncotelic Therapeutics vs. Processa Pharmaceuticals | Oncotelic Therapeutics vs. Advanced Proteome Therapeutics | Oncotelic Therapeutics vs. Cellectis SA | Oncotelic Therapeutics vs. ChitogenX |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |